Guillain-Barre Syndrome - A Frequent Immune-Mediated Complication of Peripheral Nerves in COVID-19

doi:10.47310/hjms.2021.v02i02.004

Contents

Abstract
Keywords

Download XML

520 Views

388 Downloads

Share this article

Letter to the Editor | Volume 2 Issue 2 (July-Dec, 2021)

Guillain-Barre Syndrome - A Frequent Immune-Mediated Complication of Peripheral Nerves in COVID-19

Finsterer J

Scorza FA

Klinik Landstrasse, Messerli Institute, Vienna, Austria ORCID: 0000-0003-2839-7305

Disciplina de Neurociência. Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM). São Paulo, Brasil 05468-901

Under a Creative Commons license

Open Access

DOI : 10.47310/hjms.2021.v02i02.004

Published

July 20, 2021

Abstract

It is important to consider that SC2-GBS is not as rare as suggested and can occur even in cases of mild or subclinical SARS-CoV-2 infections. The subtype distribution of SC2-GBS includes various forms, with AIDP being the most common worldwide. Additionally, the severity of COVID-19 symptoms does not necessarily correlate with the severity of SC2-GBS. Further research is needed to understand the mechanisms underlying SC2-GBS and its association with SARS-CoV-2 infection.

Keywords

SARS-CoV-2

COVID-19

Polyradiculitis

Electromyography

Nerve conduction studies

Guillain-Barre.

Download PDF

Download PDF

Download PDF

Download PDF

Download PDF